Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03803683 · ClinicalTrials.gov registry record · NA

Improving Health Outcomes in Young Cisgender Men and Transgender Women (mLab App)

A NA study of HIV Infections, sponsored by Rebecca Schnall, RN, MPH, PhD.

Completed
Registry status
NA
Development phase
525
Enrollment target
2
Study locations

NCT03803683: Completed NA study of HIV Infections, sponsored by Rebecca Schnall, RN, MPH, PhD.

NCT03803683 is a NA study of HIV Infections that has completed, run by Rebecca Schnall, RN, MPH, PhD. The registered enrollment target is 525 participants, above the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (18% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03803683, a NA study of HIV Infections, has completed, sponsored by Rebecca Schnall, RN, MPH, PhD.

COMPLETED
Registry status
NA
Development phase
525 participants
Enrollment target
2
Study locations

Study Summary

The mLab App combines HIV prevention information with push notifications/reminders to complete HIV testing and an automated image processing feature to provide real-time feedback on home-based HIV test results. Theoretically-guided by the Health Information Technology Usability Evaluation Model (Health-ITUEM), the proposed project will refine and test a next-generation diagnostic intervention delivered on a mobile platform to improve HIV testing and linkage-to-care outcomes among youth living with and at-risk for HIV. Given the pervasiveness, low cost, and convenience of mobile technology, the investigators hope that the App can help achieve the goals of the National HIV/AIDS Strategy in the US by increasing the number of persons living with HIV who know their serostatus, decreasing HIV-related disparities, and ultimately reducing the risk of HIV transmission and acquisition.

Primary Outcome

Total number of youth tested for HIV at 6 months

Conditions Studied

HIV Infections

Interventions

  • DEVICE mLab App
  • BEHAVIORAL HIV Prevention Information
  • DEVICE HIV Home Tests

Study Locations (2)

Illinois

  • Lurie Children's Hospital - Chicago

New York

  • Columbia University School of Nursing - New York

Trial Details

FieldValue
Enrollment Target 525 participants
Start Date 2020-01-21
Est. Completion 2023-10-02
Phase NA
Rebecca Schnall, RN, MPH, PhD

1 total trials

What the finished NCT03803683 record still lists

NCT03803683 is an interventional study that assigns participants to a tested intervention. The registered 525 participants enrollment target is mid-sized for trials with a published cap, above the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (18% higher).

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 3 interventions - of which mLab App is the first listed.

NCT03803683 reports a single indexed study location in Illinois, New York.

Frequently Asked Questions

What is clinical trial NCT03803683 about?

NCT03803683 is a clinical study titled "Improving Health Outcomes in Young Cisgender Men and Transgender Women (mLab App)". The mLab App combines HIV prevention information with push notifications/reminders to complete HIV testing and an automated image processing feature to provide real-time feedback on home-based HIV test results. Theoretically-guided by the Health Information Technology Usability Evaluation Model (Hea...

What is the current status of trial NCT03803683?

This trial is currently completed. It is a NA study. The enrollment target is 525 participants. The study started on 2020-01-21. Estimated completion is 2023-10-02.

What conditions does trial NCT03803683 study?

This clinical trial studies the following conditions: HIV Infections.

What interventions are being tested in trial NCT03803683?

The interventions under investigation include: mLab App (DEVICE), HIV Prevention Information (BEHAVIORAL), HIV Home Tests (DEVICE).

Who is sponsoring clinical trial NCT03803683?

This trial is sponsored by Rebecca Schnall, RN, MPH, PhD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03803683 being conducted?

This trial has 2 study locations across Illinois, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03803683's enrollment target sits among peer trials

525 59th of 542 higher than 483 of 542 other HIV Infections trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04769492 · 525 participants · NA

    #ChopViolence/#ChopHIV

  • NCT05260047 · 525 participants · NA

    Culturally Responsive Community Driven Substance Use Recovery for Black and Latinx Population

  • NCT05620719 · 525 participants · NA

    Multisite Advancement of Research on Chronic Posttraumatic Headache

  • NCT06496646 · 525 participants · NA

    Antidepressant Adherence for Depressed Adults in Primary Care

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT03803683, the US trial registry maintained by the National Library of Medicine. NCT03803683 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.